News – Page 575 – Endpoints News

Indian manufacturer called out for rust and lackluster records; Spanish CMO signs 10-year commitment to make mRNA ...

4 years ago

A famous pug, a girl and an original song headline Horizon’s latest rare disease awareness campaign

4 years ago

Psychedelics biotech to enter clinic in Canada; Months after emerging from stealth, Walking Fish closes Series A

4 years ago

Roche signs neurodegeneration pact with stealthy biotech, primarily focusing on ALS

4 years ago

Powerful pack of senators pushes DOJ for a criminal probe of Sacklers' role in opioid epidemic

4 years ago

Biotech billionaire Dietmar Hopp digs deeper to back one of the drug developers in his portfolio

4 years ago

With $200M in new cash, Synthego wants to become the manufacturing bedrock for CRISPR. But where are its customers?

4 years ago

Yumanity's ugly demise continues with plans to axe 60% of staff in search for 'strategic alternatives'

4 years ago

Avalo Therapeutics shuffles leadership team as the flailing biotech searches for a port in the storm

4 years ago

Covid-19 roundup: Pfizer, BioNTech's Omicron-specific shot delayed as surge wanes, while Moderna eyes August rollout

4 years ago

Innovent claims two PhIII wins for PCSK9 antibody, but non-China strategy remains unclear

4 years ago

FDA says volume manufacturing deadline is not a requirement after drugmakers lash out

4 years ago

In wake of Lander resignation, Biden taps Francis Collins, Alondra Nelson to fill top science roles

4 years ago

J&J jumps on the RNA bandwagon, inking discovery deal with Remix for a potentially new class of drugs

4 years ago

NIH's top vaccine director retires, adding to the exodus of government vaccine expertise

4 years ago

EMA might deny Merck's molnupiravir conditional marketing authorization — report

4 years ago

A new analyst report spotlights 3 more deaths, ARIA among Alzheimer's patients taking Aduhelm

4 years ago

Is the battle over 'skinny' generic labels headed to the Supreme Court?

4 years ago

As patent debate swirls, BioNTech CEO promises not to enforce Covid vaccine IP rights in Africa — report

4 years ago

As Omicron fears fade, pandemic restrictions are being dismantled. And that's a big deal for some biopharmas

4 years ago

Merck taps three oncology chiefs to take over Human Health, divvying up role held by Frank Clyburn

4 years ago

BioNTech unveils a 'cheap' shipping-container kit for manufacturing vaccines globally

4 years ago

Editorial: With Califf confirmed, FDA needs to return to priorities lost to the pandemic and improve its messaging

4 years ago

Putting its pivotal failure in the rearview mirror, AstraZeneca scores an EU nod for its lupus drug

4 years ago

First page Previous page 572 573 574575576 577 578 Next page Last page